BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19948444)

  • 1. Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer.
    Karl A; Tritschler S; Hofmann S; Stief CG; Schindlbeck C
    Eur J Med Res; 2009 Nov; 14(11):487-90. PubMed ID: 19948444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
    Guzzo TJ; McNeil BK; Bivalacqua TJ; Elliott DJ; Sokoll LJ; Schoenberg MP
    Urol Oncol; 2012; 30(1):44-8. PubMed ID: 20005748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
    Abrahamsson J; Aaltonen K; Engilbertsson H; Liedberg F; Patschan O; Rydén L; Sjödahl G; Gudjonsson S
    Urol Oncol; 2017 Oct; 35(10):606.e9-606.e16. PubMed ID: 28676151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer.
    Pagliarulo V; Ancona P; Petitti T; Salerno A; Spadavecchia R; Di Stasi S; Cormio L; Maurizio B; Carrieri G; Ditonno P
    Clin Genitourin Cancer; 2017 Aug; 15(4):455-462. PubMed ID: 28024950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
    Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
    Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
    Cegan M; Kolostova K; Matkowski R; Broul M; Schraml J; Fiutowski M; Bobek V
    Int J Clin Exp Pathol; 2014; 7(10):7164-71. PubMed ID: 25400813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.
    Madersbacher S; Hochreiter W; Burkhard F; Thalmann GN; Danuser H; Markwalder R; Studer UE
    J Clin Oncol; 2003 Feb; 21(4):690-6. PubMed ID: 12586807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical study of radical cystectomy for lymph node positive bladder cancer].
    Kajiwara T; Kashibuchi K; Shinohara M; Munakata A; Itakura H; Inoue S; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1997 Dec; 88(12):992-6. PubMed ID: 9465598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
    Kouba EJ; Lentz A; Wallen EM; Pruthi RS
    Urol Oncol; 2009; 27(5):486-90. PubMed ID: 18555706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
    Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
    Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
    Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L
    BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.